Why ICER Can’t Be Trusted

ICER has come out with a response to what it defines as myths about it’s funding, approach and mission.  The rejoinder is an excellent example of President Kennedy’s observation that “the great enemy of the truth is very often not the lie, deliberate, contrived and...

ICER Hires More Human Shields for Rationing

As I have previously discussed,  ICER’s initiative to revisit the representatitiveness and scientific validity of his QALY based assessments of drug prices and access is really a crude political makeover.  The recent appointment of so-called patient and consumer...

ICER: a Cancer Survivor/Marathon Runner’s Perspective

This post on ICER from a patient’s perspective is by Don Wright.  Don is a lawyer living and working in Minnesota and  has been running marathons since 2002.   In 2003 he was diagnosed with multiple myeloma, a blood cancer with no cure.  He went on an...

Peter Loftus Lead Astray by ICER on Cancer Drug Costs

Peter Loftus’ article Combination Drug Therapies for Cancer Show Promise at Higher Potential Cost relies on opinion rather than facts. And the opinion he relies on comes from an organization that combines factoids with fiction to demonstrate that new drugs are...